Current therapies and challenges for the treatment of Staphylococcus aureus biofilm‐related infections
Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy · 2023-08 · 43 (8) · 816-832
DOI: 10.1002/phar.2806 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, online erschienen am 14.05.2023. Verfasst von Nikki N Tran und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy, The Ohio State University Wexner Medical Center - The James Cancer Hospital and Solove Research Institute, Columbus, Ohio, US…. Hauptthemen laut MEDLINE: Staphylococcal Infections, Community-Acquired Infections, Methicillin-Resistant Staphylococcus aureus. Die Arbeit wurde bisher 74-mal zitiert (Crossref) und nennt 177 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Staphylococcus aureus is a major cause of nosocomial and community‐acquired infections and contributes to significant increase in morbidity and mortality especially when associated with medical devices and in biofilm form. Biofilm structure provides a pathway for the enrichment of resistant and persistent phenotypes of S. aureus leading to relapse and recurrence of infection. Minimal diffusion of antibiotics inside biofilm structure leads to heterogeneity and distinct physiological activity. Additionally, horizontal gene transfer between cells in proximity adds to the challenges associated with eradication of biofilms. This narrative review focuses on biofilm‐associated infections caused by S. aureus , the impact of environmental conditions on biofilm formation, interactions inside biofilm communities, and the clinical challenges that they present. Conclusively, potential solutions, novel treatment strategies, combination therapies, and reported alternatives are discussed.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pharmacy, The Ohio State University Wexner Medical Center - The James Cancer Hospital and Solove Research Institute, Columbus, Ohio, USA.
- Department of Clinical Pharmacy and Outcomes Sciences, Medical University of South Carolina College of Pharmacy, Charleston, South Carolina, USA.
- Department of Pharmacy Services, Medical University of South Carolina Shawn Jenkins Children's Hospital, Charleston, South Carolina, USA.
- Institute of Medical Science, Temerty Faculty of Medicine, University of Toronto, Toronto, Ontario, Canada.
- P3 Research Laboratory, Division of Outcomes and Translational Sciences, College of Pharmacy, The Ohio State University, Columbus, Ohio, USA.
ORCID-Profile: Sarah C J Jorgensen, Razieh Kebriaei
Zitieren
APA
Tran, N. N., Morrisette, T., Jorgensen, S. C. J., Orench-Benvenutti, J. M., & Kebriaei, R. (2023). Current therapies and challenges for the treatment of Staphylococcus aureus biofilm‐related infections. Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, 43(8), 816-832. https://doi.org/10.1002/phar.2806
Vancouver
Tran NN, Morrisette T, Jorgensen SCJ, Orench-Benvenutti JM, Kebriaei R. Current therapies and challenges for the treatment of Staphylococcus aureus biofilm‐related infections. Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy. 2023;43(8):816-832. doi:10.1002/phar.2806
BibTeX
@article{Tran2023,
author = {Tran, Nikki N and Morrisette, Taylor and Jorgensen, Sarah C J and Orench-Benvenutti, José M and Kebriaei, Razieh},
title = {Current therapies and challenges for the treatment of Staphylococcus aureus biofilm‐related infections},
journal = {Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy},
year = {2023},
volume = {43},
number = {8},
pages = {816--832},
doi = {10.1002/phar.2806}
}
EUVIMED